We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 07, 2021

Adjuvant Trastuzumab With or Without Chemotherapy in Stage 1 pT1N0 HER2+ Breast Cancer

Breast Cancer Research and Treatment


Additional Info

Breast Cancer Research and Treatment
Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis
Breast Cancer Res Treat 2021 Oct 16;[EPub Ahead of Print], L Cao, R Shenk, N Stabellini, ME Miller, CW Towe, AJ Montero

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading